Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaush MeditechHKSE:02407 +0.61%67 OCF Margin % is 16.54% as of Dec. 2025, which is 22% above its 10-year median of 13.51. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.39 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Gaush Meditech ranks better than 59.88% on this metric.
The historical rank and industry rank for Gaush Meditech's OCF Margin % or its related term are showing as below:
HKSE:02407'
s OCF Margin % Range Over the Past 10 Years
Min: 7.55 Med: 13.51 Max: 18.7
Current: 10.48
During the past 7 years, the highest OCF Margin % of Gaush Meditech was 18.70%. The lowest was 7.55%. And the median was 13.51%.
HKSE:02407's OCF Margin % is ranked better than 59.88% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs HKSE:02407: 10.48
Gaush Meditech OCF Margin % Related Terms
Gaush Meditech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Gaush Meditech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02407 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Gaush Meditech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) has a OCF Margin % of 16.54% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gaush Meditech and its competitors. This is 22% above median its historical median of 13.51. Over the past decade, Gaush Meditech's OCF Margin % has ranged from 7.55 to 18.70. According to the industry distribution chart, Gaush Meditech ranks #327 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 40.1%.
Is Gaush Meditech's OCF Margin % too high?
Gaush Meditech's current OCF Margin % of 16.54% is 22% above median its 10-year median of 13.51. Over the past 10 years, this metric has ranged from a low of 7.55 to a high of 18.70. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Gaush Meditech's value of 16.54% is 184.2% above this industry median. Based on the distribution chart, Gaush Meditech ranks #327 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gaush Meditech ranks #327 out of 815 companies for OCF Margin %. This puts Gaush Meditech in the upper half of its industry. The industry median OCF Margin % is 5.82. Gaush Meditech's value of 16.54% is 184.2% above this benchmark. Historically, Gaush Meditech's own OCF Margin % has ranged from 7.55 to 18.70 over the past decade. While the company's 10-year median is 13.51 vs. the industry median of 5.82, Gaush Meditech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaush Meditech's current OCF Margin % of 16.54% is 184.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gaush Meditech and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaush Meditech's current OCF Margin % is 16.54%, which is 22% above median its own 10-year median of 13.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.39, compared to a current price of HK$4.93 — trading 63.2% below its estimated fair value. The current OCF Margin % is 16.54%, which is 22% above median its 10-year median of 13.51 and 184.2% above the Medical Devices & Instruments industry median of 5.82. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current OCF Margin % is 16.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gaush Meditech (HKSE:02407) Overvalued in 2026?
Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued.
The current stock price of HK$4.93 is trading 63.2% below its estimated GF Value™ of HK$13.39.
GuruFocus considers Gaush Meditech to be Possible Value Trap.
Key valuation signals for HKSE:02407:
OCF Margin %: 16.54% (22% above median its 10-year median of 13.51)
GF Value™: HK$13.39 vs. price of HK$4.93 (63.2% below fair value)
Industry Position: 184.2% above the Medical Devices & Instruments median (#327 of 815)
No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score
Get the complete analysis for HKSE:02407
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02407 has been successfully added to your 
